FNY Managed Accounts’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1K Sell
15
-30
-67% -$2.32K ﹤0.01% 548
2017
Q4
$3K Buy
+45
New +$3.01K ﹤0.01% 468
2017
Q3
Sell
-652
Closed -$41K 689
2017
Q2
$41K Sell
652
-50
-7% -$3.08K 0.41% 57
2017
Q1
$40K Buy
+702
New +$41.9K 0.12% 243

Other funds holding USNA

FNY Managed Accounts's USNA Position: Q1 2018 in Review

FNY Managed Accounts reduced its Usana Health Sciences (USNA) stake by 67% in Q1 2018, selling an estimated $2.32K and leaving 15 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #548.

FNY Managed Accounts first reported a position in USNA in Q1 2017 and has held it in 4 quarters since. The position peaked at $41K in Q2 2017. 168 funds tracked by Wall St. Rank hold USNA as of Q1 2018.

  • FNY Managed Accounts held 15 shares of Usana Health Sciences worth $1K as of Q1 2018.
  • FNY Managed Accounts sold 30 Usana Health Sciences shares in Q1 2018, an estimated $2.32K.
  • Usana Health Sciences made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #548 holding.
  • FNY Managed Accounts first reported a position in Usana Health Sciences in Q1 2017 and has held it in 4 quarters since.
  • FNY Managed Accounts's Usana Health Sciences position peaked at $41K in Q2 2017.
  • 168 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.